You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

membranous nephropathy in stage I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)

Terminated
  • Idiopathic Membranous Nephropathy
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Feb 2, 2022

Primary Membranous Nephropathy Trial in Beijing (B007)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Beijing, China
    Peking university first hospital
Dec 20, 2022

Idiopathic Membranous Nephropathy

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • Obinutuzumab Injection
  • (no location specified)
May 8, 2023

Primary Membranous Nephropathy Trial in Worldwide (Obinutuzumab, Tacrolimus, Methylprednisolone)

Recruiting
  • Primary Membranous Nephropathy
  • Mesa, Arizona
  • +75 more
Jan 10, 2023

Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)

Not yet recruiting
  • Glomerulonephritis, Membranous
  • Nephrotic Syndrome，Idiopathic
  • Rituximab (genetical recombination)
  • Placebo
  • Anjo, Aichi, Japan
  • +7 more
Jun 13, 2023

Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system

Not yet recruiting
  • Nephropathy
  • +2 more
  • Huaier granule
  • +2 more
  • (no location specified)
Apr 20, 2023

T- and B-Cell Subpopulations in Membranous Nephropathy

Recruiting
  • Membranous Nephropathy
  • +2 more
    • Istanbul, Turkey
      Istanbul University
    May 31, 2023

    Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

    Completed
    • Glomerulonephritis, Membranous
    • antiPLA2R Positive
    • Azusa, California
    • +44 more
    Dec 12, 2022

    Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • Garran, Australian Capital Territory, Australia
    • +12 more
    Nov 1, 2023

    Primary Membranous Nephropathy Trial in Beijing (MIL62, Cyclosporine)

    Recruiting
    • Primary Membranous Nephropathy
    • Beijing, Beijing, China
      Peking University First Hospital
    May 26, 2022

    Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive Trial in Worldwide (MOR202)

    Active, not recruiting
    • Glomerulonephritis
    • +2 more
    • Tbilisi, Georgia
    • +24 more
    Aug 23, 2022

    Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, Cyclophosphamide, Rituximab)

    Recruiting
    • Idiopathic Membranous Nephropathy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 18, 2022

    Extramembranous Glomerulopathy Trial in Nice (Blood sample)

    Recruiting
    • Extramembranous Glomerulopathy
    • Blood sample
    • Nice, France
      Centre Hospitalier Universitaire de Nice
    Jun 20, 2022

    Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Aug 22, 2022

    PLA2R-IgG4 Detection Kit

    Enrolling by invitation
    • Membranous Nephropathy - PLA2R Induced
    • Kidney Diseases-except Membranous Nephropathy
      • Hangzhou, China
        ZhejiangBiostar
      May 6, 2023

      Membranous Nephropathy, Nephrotic Syndrome Trial in Canada, United States (Belimumab, Placebo for Belimumab, Rituximab)

      Recruiting
      • Membranous Nephropathy
      • Nephrotic Syndrome
      • Birmingham, Alabama
      • +16 more
      Sep 22, 2022

      Prognostic Model of Rituximab in the Treatment of MN

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • (no location specified)
      Dec 28, 2022

      Prognostic Model of TAC in the Treatment of MN

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • (no location specified)
      Dec 28, 2022

      Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • glucocorticoid + tacrolimus
      • (no location specified)
      Dec 28, 2022

      Prognostic Model of GC/CTX in the Treatment of MN

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • glucocorticoid + cytoxan
      • (no location specified)
      Dec 28, 2022

      Efficacy Trial in Beijing (Prednisone, ciclosporin and mycophenolate mofetil, Ponticelli Regimen)

      Completed
      • Efficacy
      • Prednisone, ciclosporin and mycophenolate mofetil
      • Ponticelli Regimen
      • Beijing, Beijing, China
      • +1 more
      Feb 2, 2022

      Membranous Nephropathy Trial in China (efgartigimod IV, )

      Recruiting
      • Membranous Nephropathy
      • efgartigimod IV
      • placebo
      • Changsha, China
      • +8 more
      Apr 11, 2023

      Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)

      Not yet recruiting
      • Primary Membranous Nephropathy
      • (no location specified)
      May 16, 2023

      Urinary Biomarker in Membranous Glomerulonephritis

      Not yet recruiting
      • Membranous Nephropathy
      • urinary markers
      • (no location specified)
      Jan 18, 2023

      Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)

      Recruiting
      • Idiopathic Membranous Nephropathy
      • 100 mg AP1189
      • Placebo
      • Aarhus, Denmark
        Aarhus Universitetshospital
      Sep 21, 2021